在IgA病中对蛋白质编码变体的全基因组协会分析
Ming Li1,2,3, Yan-Na Wang1, Ling Wang4
1Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Journal of the American Society of Nephrology : JASN
|October 3, 2023
概括
这项研究确定了血管内皮生长因子A (VEGFA) 的一种罕见变异,显著增加了IgA脏病风险. 一种常见的PKD1L3变体与较低的球蛋白水平有关,扩大了对IgA病遗传学的理解.
科学领域:
- 遗传学 遗传学 是一个
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
背景情况:
- 全基因组关联研究 (GWAS) 已经确定了许多IgA脏病 (IgAN) 易感度位点.
- 然而,罕见和低频编码变体在IGAN病原发生方面仍未得到充分研究.
研究的目的:
- 调查罕见和低频编码变体在IgA病敏感性中的作用.
- 识别与IgA病风险和进展相关的新型遗传变异.
主要方法:
- 在汉族人群中进行了一项大规模的,三阶段的基于exome芯片的关联研究.
- 使用测序分析来识别罕见的编码变体.
- 用分子动态模拟来评估VEGFA突变对蛋白质结构和功能的影响.
主要成果:
- 血管内皮生长因子A (VEGFA) 的罕见非同义变体与IgA脏病的风险增加两倍显著相关.
- 在PKD1L3中,一种常见的非同义变异与较低的哈普托格洛宾蛋白水平有关.
- 发现的罕见VEGFA变体显示出改变蛋白质结构和增加受体结合的潜力,并与IgAN进展风险增加有关.
结论:
- 该研究发现了VEGFA和PKD1L3中的新风险变异,有助于理解IgA瘤遗传结构.
- 这些发现凸显了研究复杂疾病中的罕见编码变异的重要性.
更多相关视频
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
13.0K
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.8K
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K
